AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31247643 — Biomarker: PTGES mRNA
Type: Predictive Biomarker (PRD)
Genes: PTGES; MGST1L1; MPGES1; PGES; PIG12
Study 29618599 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 29618599 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 15866643 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8184812 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 26582645 — Biomarker: IDH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: IDH1; PICD
Study 26582645 — Biomarker: IDH2 mRNA
Type: Predictive Biomarker (PRD)
Genes: IDH2
Study 26582645 — Biomarker: 2-hydroxyglutarate
Type: Pharmacodynamic Biomarker (PDY)
Study 18234127 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 12595913 — Biomarker: Cytochrome P450 2C19
Type: Safety Biomarker (SAF)
Genes: CYP2C19
Study 12595913 — Biomarker: CYP1A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP1A2
Study 12595913 — Biomarker: Cytochrome P450 2D6
Type: Safety Biomarker (SAF)
Genes: CYP2D6; CYP2DL1
Study 8991564 — Biomarker: MMRN1 mRNA
Type: Predictive Biomarker (PRD)
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study 8325071 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 3792347 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 29929385 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study 19002314 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12885747 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1752075 — Biomarker: Hematologic response
Type: Surrogate Endpoint (SUR)
Study 28911144 — Biomarker: Thyroid stimulating hormone
Type: Safety Biomarker (SAF)
Study 17904989 — Biomarker: SPTB mRNA
Type: Predictive Biomarker (PRD)
Genes: SPTB; SPTB1
Study 8873539 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1415367 — Biomarker: Beta-2-microglobulin
Type: Safety Biomarker (SAF)
Genes: B2M; CDABP0092; HDCMA22P
Study 20164112 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 19438584 — Biomarker: AR mRNA
Type: Predictive Biomarker (PRD)
Genes: AR; DHTR; NR3C4
Study 30632656 — Biomarker: PAH mRNA
Type: Predictive Biomarker (PRD)
Genes: PAH
Study 21133820 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17234518 — Biomarker: CAV1 mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAV1; CAV
Study 10518847 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 27508917 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 11837383 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 8665543 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1706014 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28751244 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 14508197 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8968432 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1319735 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 11703423 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 31274491 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24460005 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 19223559 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study 6165954 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15702140 — Biomarker: TYR mRNA
Type: Predictive Biomarker (PRD)
Genes: TYR
Study 30004570 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 18035199 — Biomarker: MVP mRNA
Type: Predictive Biomarker (PRD)
Genes: MVP; LRP
Study 18035199 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 10490784 — Biomarker: CIT mRNA
Type: Predictive Biomarker (PRD)
Genes: CIT; CRIK; KIAA0949; STK21
Study 1657501 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22699241 — Biomarker: EBF1 mRNA
Type: Predictive Biomarker (PRD)
Genes: EBF1; COE1; EBF
Study 17683868 — Biomarker: EPX mRNA
Type: Predictive Biomarker (PRD)
Genes: EPX; EPER; EPO; EPP
Study 11807960 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8075030 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 31221534 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 31221534 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21246844 — Biomarker: SDS mRNA
Type: Predictive Biomarker (PRD)
Genes: SDS; SDH
Study 8309864 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 1676367 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30151703 — Biomarker: Retinoblastoma-associated protein
Type: Pharmacodynamic Biomarker (PDY)
Genes: RB1
Study 30151703 — Biomarker: RB1
Type: Predictive Biomarker (PRD)
Genes: RB; PPP1R130
Study 22944391 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 9663215 — Biomarker: TAT mRNA
Type: Predictive Biomarker (PRD)
Genes: TAT
Study 2509528 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31404623 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28987023 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 8665547 — Biomarker: DRD2
Type: Safety Biomarker (SAF)
Study 2183619 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24026600 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12535752 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 12535752 — Biomarker: Vitamin B12
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 9039444 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 29423540 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 29423540 — Biomarker: O-6-methylguanine-DNA-alkyltransferase
Type: Predictive Biomarker (PRD)
Genes: MGMT
Study 29423540 — Biomarker: ACE
Type: Safety Biomarker (SAF)
Genes: ACE1; CD143
Study 18797094 — Biomarker: GPI mRNA
Type: Predictive Biomarker (PRD)
Genes: GPI
Study 20928906 — Biomarker: MYF6 mRNA
Type: Predictive Biomarker (PRD)
Genes: MYF6; BHLHC4; MRF4
Study 10227009 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 30022544 — Biomarker: MAL mRNA
Type: Predictive Biomarker (PRD)
Genes: MAL
Study 25167977 — Biomarker: PYY mRNA
Type: Predictive Biomarker (PRD)
Genes: PYY
Study 25167977 — Biomarker: CCK mRNA
Type: Predictive Biomarker (PRD)
Genes: CCK
Study 30177038 — Biomarker: APC mRNA
Type: Predictive Biomarker (PRD)
Genes: APC; DP2.5
Study 26808546 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 26808546 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26808546 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 26808546 — Biomarker: Hypoxia-inducible factor 1-alpha
Type: Predictive Biomarker (PRD)
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study 26808546 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 26808546 — Biomarker: Mucin-1
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: MUC1; PUM
Study 24115735 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20484334 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 16339586 — Biomarker: HLA-A
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 28756115 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study 26786311 — Biomarker: Vitamin B12
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 24163081 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15086284 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 31551192 — Biomarker: miR-137
Type: Safety Biomarker (SAF)
Genes: MIR137
Study 27745812 — Biomarker: Serum bactericidal antibody
Type: Surrogate Endpoint (SUR)
Study 16053850 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 16053850 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11943931 — Biomarker: APC mRNA
Type: Predictive Biomarker (PRD)
Genes: APC; DP2.5
Study 10065788 — Biomarker: CD46 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD46; MCP; MIC10
Study 10065788 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 2207824 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29121415 — Biomarker: MAP2K1 mRNA
Type: Predictive Biomarker (PRD)
Genes: MAP2K1; MEK1; PRKMK1
Study 29121415 — Biomarker: MAP2K2 mRNA
Type: Predictive Biomarker (PRD)
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study 29121415 — Biomarker: NF1 mRNA
Type: Predictive Biomarker (PRD)
Genes: NF1
Study 23536942 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 18687385 — Biomarker: F3 mRNA
Type: Predictive Biomarker (PRD)
Genes: F3
Study 16184836 — Biomarker: HLA-C
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: HLA-JY3, D6S204, PSORS1
Study 29379278 — Biomarker: PBX1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PBX1; PRL
Study 27893109 — Biomarker: TRPV1 mRNA
Type: Predictive Biomarker (PRD)
Genes: TRPV1; VR1
Study 8871884 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 4063689 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 3365327 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18615004 — Biomarker: ADRB1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ADRB1; ADRB1R; B1AR
Study 18615004 — Biomarker: ADRB2 mRNA
Type: Predictive Biomarker (PRD)
Genes: ADRB2; ADRB2R; B2AR
Study 15542574 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 18378136 — Biomarker: CS mRNA
Type: Predictive Biomarker (PRD)
Genes: CS
Study 15653378 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 12716753 — Biomarker: LIPE mRNA
Type: Predictive Biomarker (PRD)
Genes: LIPE
Study 12716753 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 12716753 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22972835 — Biomarker: REM1 mRNA
Type: Predictive Biomarker (PRD)
Genes: REM1; GES; REM
Study 20806117 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 11875316 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 11875316 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 181258 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 28549783 — Biomarker: MYCN mRNA
Type: Predictive Biomarker (PRD)
Genes: MYCN; BHLHE37; NMYC
Study 28549783 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 8140565 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20225536 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 20225536 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16249460 — Biomarker: PPARG mRNA
Type: Predictive Biomarker (PRD)
Genes: PPARG; NR1C3
Study 8767563 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27790530 — Biomarker: EBP mRNA
Type: Predictive Biomarker (PRD)
Genes: EBP
Study 22349389 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22349389 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 22349389 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 18156406 — Biomarker: MTHFR
Type: Safety Biomarker (SAF)
Study 16628625 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 18524784 — Biomarker: BAG3 mRNA
Type: Predictive Biomarker (PRD)
Genes: BAG3; BIS
Study 18524784 — Biomarker: SPIN1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SPIN1; OCR; SPIN
Study 18524784 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 7852526 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 29557414 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 29557414 — Biomarker: GGT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GGT1; GGT
Study 26489835 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 24944159 — Biomarker: Tyrosine-protein kinase ABL1
Type: Pharmacodynamic Biomarker (PDY)
Genes: ABL1; ABL; JTK7
Study 10333347 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7795831 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28525534 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study 25915145 — Biomarker: SST mRNA
Type: Predictive Biomarker (PRD)
Genes: SST
Study 22108775 — Biomarker: Cytochrome P450 2C19
Type: Safety Biomarker (SAF)
Genes: CYP2C19
Study 15311147 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3093915 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26842902 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 24576226 — Biomarker: AMH mRNA
Type: Predictive Biomarker (PRD)
Genes: AMH; MIF
Study 11939913 — Biomarker: ARX mRNA
Type: Predictive Biomarker (PRD)
Genes: ARX
Study 2144819 — Biomarker: GNRH1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GNRH1; GNRH; GRH; LHRH
Study 2144819 — Biomarker: CPA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CPA1; CPA
Study 28898281 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 25805647 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7542301 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 11322176 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 9478089 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 3307517 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29157872 — Biomarker: SDS mRNA
Type: Predictive Biomarker (PRD)
Genes: SDS; SDH
Study 26154547 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 23846759 — Biomarker: CAPS mRNA
Type: Predictive Biomarker (PRD)
Genes: CAPS
Study 23846759 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17047401 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 17047401 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 17047401 — Biomarker: Serum triglycerides
Type: Surrogate Endpoint (SUR)
Study 12767538 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9021380 — Biomarker: Serum luteinizing hormone
Type: Surrogate Endpoint (SUR)
Study 9021380 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 30894213 — Biomarker: GEM mRNA
Type: Predictive Biomarker (PRD)
Genes: GEM; KIR
Study 30894213 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 19678777 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11344184 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 9700978 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 9700978 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28365238 — Biomarker: Epidermal growth factor
Type: Monitoring Biomarker (MOI)
Genes: EGF
Study 28365238 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 10700656 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 10700656 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 10700656 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 9568324 — Biomarker: Lactate dehydrogenase
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 9568324 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 30097359 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18506677 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 16430197 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 16430197 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 16430197 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 30567626 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 16784967 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 16784967 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 8691923 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7114076 — Biomarker: Complement C4
Type: Monitoring Biomarker (MOI)
Study 26672246 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11477729 — Biomarker: CFTR mRNA
Type: Predictive Biomarker (PRD)
Genes: CFTR; ABCC7
Study 3059882 — Biomarker: AMN mRNA
Type: Predictive Biomarker (PRD)
Genes: AMN; UNQ513/PRO1028
Study 25312436 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16320073 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 29521134 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 29521134 — Biomarker: CYP3A5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A5
Study 12568205 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8580622 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 138578 — Biomarker: Cyclic guanosine monophosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 138578 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31248548 — Biomarker: CFH mRNA
Type: Predictive Biomarker (PRD)
Genes: CFH; HF; HF1; HF2
Study 30168004 — Biomarker: Intact parathyroid hormone
Type: Predictive Biomarker (PRD)
Study 24560135 — Biomarker: PPARA mRNA
Type: Predictive Biomarker (PRD)
Genes: PPARA; NR1C1; PPAR
Study 24560135 — Biomarker: Peroxisome proliferator-activated receptor alpha
Type: Safety Biomarker (SAF)
Genes: PPARA
Study 20636275 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 12696650 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 31027300 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 21062616 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 15776301 — Biomarker: Alpha-glutathione S-transferase
Type: Safety Biomarker (SAF)
Study 9875580 — Biomarker: DSP mRNA
Type: Predictive Biomarker (PRD)
Genes: DSP
Study 7840322 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 27631386 — Biomarker: MAS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: MAS1; MAS
Study 25978742 — Biomarker: Valproic acid
Type: Pharmacodynamic Biomarker (PDY)
Study 19297309 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12968238 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 1623694 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25884010 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25884010 — Biomarker: Interleukin 18
Type: Safety Biomarker (SAF)
Genes: IL18; IGIF; IL1F4
Study 11399215 — Biomarker: GGT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GGT1; GGT
Study 3435119 — Biomarker: Lactate dehydrogenase
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 25127725 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24369254 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 14527092 — Biomarker: Thymidylate synthase 
Type: Predictive Biomarker (PRD)
Genes: TYMS; TS; OK/SW-cl.29
Study 10920066 — Biomarker: TH mRNA
Type: Predictive Biomarker (PRD)
Genes: TH; TYH
Study 3993553 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 3993553 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18774469 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 10660867 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31663833 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 31053510 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 22836707 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 22836707 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 22836707 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8789545 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 8789545 — Biomarker: MBP mRNA
Type: Predictive Biomarker (PRD)
Genes: MBP
Study 8789545 — Biomarker: IL4
Type: Safety Biomarker (SAF)
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 8789545 — Biomarker: Interleukin 5
Type: Predictive Biomarker (PRD)
Genes: IL5
Study 15829326 — Biomarker: ASRGL1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ASRGL1; ALP; CRASH
Study 15858936 — Biomarker: LPO mRNA
Type: Predictive Biomarker (PRD)
Genes: LPO; SAPX
Study 30192210 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23540718 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 25869603 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 20716911 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15231367 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 22231921 — Biomarker: PDXP mRNA
Type: Predictive Biomarker (PRD)
Genes: PDXP; CIN; PLP; PLPP